Hey Peter,
<br />
<br />not sure about the 770/809 trials but seems like vertex will be filing for VX-770 approval this year.
<br />
<br />"We are in a unique position, as just behind telaprevir is VX-770, a medicine in development that aims to treat the underlying cause of cystic fibrosis. We...